How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?
Neurodegener Dis
; 13(2-3): 197-9, 2014.
Article
in En
| MEDLINE
| ID: mdl-23942173
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Randomized Controlled Trials as Topic
/
Outcome Assessment, Health Care
/
Neuroprotective Agents
/
Translational Research, Biomedical
/
Alzheimer Disease
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Neurodegener Dis
Journal subject:
NEUROLOGIA
Year:
2014
Type:
Article
Affiliation country:
Canada